Related Experiment Videos
Experiences with octreotide in acromegaly
J A O'Hare1, F Abuaisha, T Cotter
1University College, Cork.
Irish Journal of Medical Science
|February 1, 1993
Summary
Octreotide, a somatostatin analogue, effectively treated acromegaly in three patients. This therapy significantly lowered growth hormone and insulin-like growth factor-1 levels, improving patient outcomes.
Area of Science:
- Endocrinology
- Neuroendocrinology
Background:
- Acromegaly is a disorder caused by excess growth hormone (GH).
- Somatostatin analogues like octreotide are used to manage GH excess.